BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension
BREEZE:一项开放标签临床研究,旨在评估曲前列尼尔吸入粉剂(商品名:Tyvaso DPI™)在肺动脉高压患者中的安全性和耐受性。
期刊:Pulmonary Circulation
影响因子:2.5
doi:10.1002/pul2.12063
Spikes, Leslie A; Bajwa, Abubakr A; Burger, Charles D; Desai, Sapna V; Eggert, Michael S; El-Kersh, Karim A; Fisher, Micah R; Johri, Shilpa; Joly, Joanna M; Mehta, Jinesh; Palevsky, Harold I; Ramani, Gautam V; Restrepo-Jaramillo, Ricardo; Sahay, Sandeep; Shah, Trushil G; Deng, Chunqin; Miceli, Melissa; Smith, Peter; Shapiro, Shelley M